(S)-Rasagiline-13C3 Mesylate
| Product Name | (S)-Rasagiline-13C3 Mesylate |
|---|---|
| Alternate Names | Rasagiline Stable Isotopes, Stable Isotopes of Rasagiline |
| CAT No. | CS-T-85428 |
| CAS No. | 1391068-00-0 |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Rasagiline |
| Smileys | CS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12 |
| Canonical Smiles | CS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12 |
| InchIKey | JDBJJCWRXSVHOQ-AJPOOADWSA-N |
| Inchl | InChI=1S/C12H13N.CH4O3S/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12;1-5(2,3)4/h1,3-6,12-13H,7-9H2;1H3,(H,2,3,4)/t12-;/m0./s1/i1+1,2+1,9+1; |
| IUPAC | methanesulfonic acid;(1S)-N-(1,2,3-13C3)prop-2-ynyl-2,3-dihydro-1H-inden-1-amine |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
(S)-Rasagiline-13C3 Mesylate is a stable isotope-labeled version of the drug Rasagiline, which is used for the treatment of Parkinson's disease. Parkinson's disease is a progressive neurological disorder that affects movement, characterized by tremors, stiffness, and difficulty with balance and coordination.
(S)-Rasagiline-13C3 Mesylate works by inhibiting the activity of monoamine oxidase-B (MAO-B), an enzyme that breaks down dopamine in the brain. Dopamine is a neurotransmitter that is essential for the proper functioning of the brain, and its deficiency is responsible for the symptoms of Parkinson's disease. By inhibiting MAO-B, (S)-Rasagiline-13C3 Mesylate increases the levels of dopamine in the brain, improving the symptoms of Parkinson's disease.
The stable isotope labeling of (S)-Rasagiline-13C3 Mesylate allows for its use in pharmacokinetic and pharmacodynamic studies, as it can be easily distinguished from the non-labeled drug. This allows researchers to study the absorption, distribution, metabolism, and excretion of the drug in the body, as well as its effects on the brain.
The chemical formula of (S)-Rasagiline-13C3 Mesylate is C12H15N13O2.CH4O3S, and its molecular weight is 353.4 g/mol. It is a white to off-white crystalline powder that is soluble in water and ethanol. The recommended dose of (S)-Rasagiline-13C3 Mesylate for the treatment of Parkinson's disease is 1 mg once daily.
Get an Instant Quote
Related Compounds
Rasagiline mesylate 13C3 | Rasagiline 13C3 | rac Rasagiline-13C3 Mesylate |